Upgrades/Downgrades
Updated: 29-Oct-26 16:57 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| FedEx | FDX | HSBC Securities | Hold » Buy | $370 | |
| Biogen | BIIB | Argus | Hold » Buy | $280 | |
| Afya | AFYA | BofA Securities | Neutral » Buy | $16 | |
| Wintrust Fin | WTFC | UBS | Neutral » Buy | $180 | |
| V.F. Corp | VFC | BNP Paribas Exane | Underperform » Neutral | $16 | |
| Hilton | HLT | Mizuho | Neutral » Outperform | $421 | |
| eBay | EBAY | Wells Fargo | Underweight » Equal Weight | $106 | |
| Constellium | CSTM | JP Morgan | Neutral » Overweight | $35 | |
| Ares Capital | ARCC | UBS | Neutral » Buy | $21 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Microsoft | MSFT | Griffin Securities | Buy » Neutral | ||
| Alnylam Pharma | ALNY | Stifel | Buy » Hold | $225 | |
| Lennox Int'l | LII | Stephens | Overweight » Equal-Weight | $350 | |
| Alkami Technology | ALKT | Craig Hallum | Buy » Hold | $16 | |
| SB Financial Group | SBFG | Brean Capital | Buy » Neutral | $32 | |
| Boston Scientific | BSX | Oppenheimer | Outperform » Perform | ||
| GBank Financial Holdings | GBFH | Brean Capital | Buy » Neutral | ||
| Alkami Technology | ALKT | KeyBanc Capital Markets | Overweight » Sector Weight | ||
| Xylem | XYL | Barclays | Overweight » Equal Weight | $104 | |
| XP | XP | Morgan Stanley | Overweight » Equal-Weight | $19 | |
| Sprouts Farmers Market | SFM | RBC Capital Mkts | Outperform » Sector Perform | $49 | |
| Sprouts Farmers Market | SFM | BofA Securities | Buy » Underperform | $47 | |
| Renasant | RNST | Raymond James | Strong Buy » Outperform | $45 | |
| Peapack-Gladstone Financial | PGC | Raymond James | Strong Buy » Mkt Perform | ||
| PayPal | PYPL | Barclays | Equal Weight » Underweight | $53 | |
| Lennox Int'l | LII | Oppenheimer | Outperform » Perform | ||
| GSK plc | GSK | Jefferies | Buy » Hold | $55.90 | |
| Fortinet | FTNT | BofA Securities | Buy » Neutral | $140 | |
| Banco Bradesco | BBD | JP Morgan | Overweight » Neutral | ||
| Artiva Biotherapeutics | ARTV | Jefferies | Buy » Hold | $4 | |
| Alphabet | GOOG | Citizens | Mkt Outperform » Mkt Perform | ||
| Alkami Technology | ALKT | Citizens | Mkt Outperform » Mkt Perform | ||
| Alkami Technology | ALKT | William Blair | Outperform » Mkt Perform | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Ormat Tech | ORA | Morgan Stanley | Overweight | $123 | |
| AirSculpt Technologies | AIRS | Lake Street | Buy | $3 | |
| Digital Turbine | APPS | Northland Capital | Outperform | $17 | |
| Castle Biosciences | CSTL | Mizuho | Outperform | $60 | |
| Fervo Energy | FRVO | Morgan Stanley | Overweight | $23 | |
| Rubrik | RBRK | Morgan Stanley | Overweight | $155 | |
| Palantir Technologies | PLTR | JP Morgan | Overweight | $262 | |
| MSG Rangers Corp | MSGR | BTIG Research | Buy | $257 | |
| Kardigan | KARD | Cantor Fitzgerald | Overweight | $50 | |
| Exxon Mobil | XOM | William Blair | Mkt Perform | ||
| ConocoPhillips | COP | William Blair | Mkt Perform | ||
| Chevron | CVX | William Blair | Outperform | ||
| Absci Corporation | ABSI | Jefferies | Buy | $14 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Coherus BioSciences | CHRS | H.C. Wainwright | Buy | $7 | |
| Agios Pharma | AGIO | H.C. Wainwright | Buy | $55 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |